查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1641734

全球細胞培養水凝膠市場按水凝膠類型、應用和最終用戶分類 - 機會分析和產業預測（2024-2035 年）

Cell Culture Hydrogel Market By Type of Hydrogel, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 321 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2023 年全球細胞培養水凝膠市場規模將達到 4 億美元，到 2035 年將達到 21.367 億美元，2024 年至 2035 年的複合年成長率為 15.0%。

細胞培養水凝膠市場-IMG1

細胞培養水凝膠是一種3D、富水的聚合物材料，旨在模擬細胞外基質（ECM）環境以在試管內培養細胞。這些水凝膠提供維持細胞功能、增殖和分化所必需的結構支撐、生化線索和機械性能。水凝膠常用於生物醫學研究，包括組織工程、再生醫學和藥物發現。

人們對幹細胞治療和研究的日益關注是推動水凝膠需求的關鍵因素，水凝膠透過模仿原生細胞環境來支持幹細胞的生長和分化。此外，藥物篩檢、類器官發育和再生醫學中從2D到3D細胞培養的轉變顯著增加了對水凝膠的需求。研究表明，與傳統的 Matrigel 支架相比，以具有可調機械性能的合成水凝膠為支撐的類器官培養物更具可重複性，並且能更準確地模擬器官樣結構。此外，藥物發現和開發中的應用正在推動市場發展。這是因為水凝膠能夠開發用於高通量藥物篩檢的 3D 模型，從而促進其在製藥和生物技術行業的應用。此外，研究癌症、心血管疾病和糖尿病等慢性疾病對先進體外模型的需求日益成長，推動了生物醫學研究中對水凝膠的需求。世界衛生組織（WHO）2023年的研究顯示，每年約有4,100萬人死於慢性病。器官晶片技術日益被採用，該技術通常採用水凝膠來模擬組織微環境，這進一步推動了市場的發展。然而，針對特定應用客製化水凝膠的特性（例如硬度、孔隙率和分解率）需要技術專長和時間，這對市場的成長造成了阻礙。此外，替代性 3D 培養方法（例如基於微載體的細胞培養和球體等無支架方法）的可用性也可能對市場成長構成挑戰。相反，水凝膠配方的創新，例如具有可調特性和刺激響應行為的智慧水凝膠，正在擴大其功能和應用。組織工程和再生醫學領域不斷增加的研究和臨床努力正在推動對水凝膠作為創建功能性組織結構的主要生物材料的需求。預計這些發展將為預測期內全球市場的擴張提供有利機會。

細胞培養水凝膠市場根據水凝膠的類型、應用、最終用戶和地區進行細分。根據水凝膠類型，市場分為天然水凝膠、合成水凝膠和混合水凝膠。根據應用，可分為癌症和幹細胞研究、組織工程和再生醫學、藥物發現和毒性測試等。根據最終用戶，市場分為製藥和生技公司、CRO、研究機構等。依地區分類，北美（美國、加拿大、墨西哥）、歐洲（德國、法國、英國、義大利、西班牙等）、亞太地區（日本、中國、印度、澳洲、韓國等）、拉丁美洲、中東、非洲分析分為四個國家（巴西、南非、沙烏地阿拉伯等）。

主要發現

根據水凝膠類型，合成水凝膠預計將在 2023 年佔據市場佔有率的主導地位，並在 2024 年至 2035 年期間實現最高複合年成長率。

根據應用，組織工程和再生醫學領域預計將在 2023 年佔據最大佔有率，而癌症和幹細胞研究領域預計將在預測期內以最高的複合年成長率成長。

根據最終用戶，製藥和生物技術公司部門將成為 2023 年的領先部門，而 CRO 部門預計將在預測期內實現最高的複合年成長率。

根據地區，北美是 2023 年全球細胞培養水凝膠市場最大的地區，而亞太地區預計在預測期內實現最高的複合年成長率。

競爭分析

相關人員的主要利益

本報告定量分析了 2023 年至 2035 年細胞培養水凝膠市場的細分市場、當前趨勢、估計和分析、動態，並確定了細胞培養水凝膠市場的突出機會。

它為市場研究提供與市場促進因素、市場限制因素和市場機會相關的資訊。

波特五力分析揭示了買家和供應商的潛力，幫助相關人員做出利潤驅動的商業決策，並加強供應商-買家網路。

對細胞培養水凝膠市場的細分進行詳細分析有助於確定市場機會。

每個地區的主要國家都根據收益貢獻進行分類。

市場公司的定位有利於基準化分析，並能清楚了解市場公司的當前地位。

報告包括對區域和全球細胞培養水凝膠市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

本報告可提供客製化（請聯絡銷售人員以了解其他費用和時間表）

  • 按產品/細分市場分析公司的市場佔有率
  • 主要公司的新產品開發/產品矩陣
  • 根據客戶興趣提供額外的公司簡介
  • 擴展公司簡介列表
  • 歷史市場資料

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 驅動程式
      • 在藥物研發和毒性測試的應用
      • 慢性病和老年人口增加
      • 3D 細胞培養需求不斷成長
    • 限制因素
      • 熟練勞動力短缺
    • 機會
      • 新興市場具有高成長潛力
      • 生物技術與生命科學進展

第4章 細胞培養水凝膠市場（按水凝膠類型）

  • 概述
  • 天然水凝膠
  • 合成水凝膠
  • 混合水凝膠

第5章 細胞培養水凝膠市場（依應用）

  • 概述
  • 癌症和幹細胞研究
  • 組織工程與再生醫學
  • 藥物研發和毒性測試
  • 其他

第6章 細胞培養水凝膠市場（依最終用戶）

  • 概述
  • 製藥和生物技術公司
  • CRO
  • 研究所
  • 其他

7. 細胞培養水凝膠市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 澳洲
    • 印度
    • 韓國
    • 其他
  • 拉丁美洲、中東和非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品映射
  • 競爭儀錶板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Corning Incorporated
  • Merck KGaA
  • Humabiologics, Inc
  • BICO
  • TheWell Bioscience Inc.
  • CD Bioparticles
  • PELOBIOTECH GmbH
  • Cell Guidance Systems
  • UPM
  • Cellendes GmbH
簡介目錄
Product Code: A325248

The cell culture hydrogel market was valued at $400.0 million in 2023 and is estimated to reach $2,136.7 million by 2035, exhibiting a CAGR of 15.0% from 2024 to 2035.

Cell Culture Hydrogel Market - IMG1

Cell culture hydrogel is a three-dimensional, water-rich polymeric materials designed to mimic the extracellular matrix (ECM) environment for culturing cells in vitro. These hydrogels provide structural support, biochemical cues, and mechanical properties essential for maintaining cellular function, proliferation, and differentiation. They are commonly used in biomedical research, including tissue engineering, regenerative medicine, and drug discovery.

Increase in focus on stem cell therapies and research is a key factors that has fueled the demand for hydrogels, which support stem cell growth and differentiation by mimicking natural cellular environments. In addition, the transition from 2D to 3D cell cultures for drug screening, organoid development, and regenerative medicine has significantly increased the demand for hydrogels. Studies have shown that organoid cultures supported by synthetic hydrogels with tunable mechanical properties enhance reproducibility and mimic organ-like structures more accurately compared to traditional Matrigel scaffolds. Moreover, rising applications in drug discovery and development fuel the growth of the market. This is attributed to the fact that hydrogels enable the development of 3D models for high-throughput drug screening, enhancing their adoption by pharmaceutical and biotechnology industries. Furthermore, rise in need for advanced in vitro models to study chronic diseases like cancer, cardiovascular conditions, and diabetes is fueling the demand for hydrogels in biomedical research. A 2023 study published by the World Health Organization revealed that approximately 41 million individuals die each year due to chronic diseases. Rise in adoption of organ-on-a-chip technologies, which often incorporate hydrogels to simulate tissue microenvironments, further propels the market. However, requirement for tailoring hydrogel properties, such as stiffness, porosity, and degradation rate, to suit specific applications demands technical expertise and time, which acts as a barrier for the market growth. Moreover, availability of alternative 3D culture methods such as microcarrier-based cell cultures or scaffold-free methods like spheroids, can pose challenges to the market growth. On the contrary, innovations in hydrogel formulations, such as smart hydrogels with tunable properties and stimuli-responsive behavior, are expanding their functionality and applications. Rise in research and clinical efforts in tissue engineering and regenerative medicine are boosting the demand for hydrogels, which serve as key biomaterials for creating functional tissue constructs. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.

The cell culture hydrogel market is segmented into type of hydrogel, application, end user, and region. By type of hydrogel, the market is segmented into natural hydrogels, synthetic hydrogels, hybrid hydrogels. By application, the market is segmented into cancer and stem cell research, tissue engineering and regenerative medicine, drug discovery and toxicology testing, and others. By end user, the market is segregated into pharmaceutical and biotechnology companies, CROs, research institution, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Key Findings

Depending on type of hydrogel, the synthetic hydrogels segment dominated the share, in terms of share, in 2023, and is expected to register the highest CAGR from 2024 to 2035.

On the basis of application, the tissue engineering & regenerative medicine segment garnered the largest share in 2023; however, the cancer & stem cell research segment is expected to grow at the highest CAGR during the forecast period.

By end user, the pharmaceutical and biotechnology companies segment was the major shareholder in 2023; however, the CROs segment is anticipated to exhibit the highest CAGR during the forecast period.

Region wise, North America was the largest shareholder in the global cell culture hydrogel market in 2023; however, Asia-Pacific is anticipated to register the highest CAGR during the forecast period.

Competitive Analysis

The key players that operate in the global cell culture hydrogel market are Corning Incorporated, Merck KGaA, Humabiologics, Inc, Cell Guidance Systems, TheWell Bioscience Inc., CD Bioparticles, BICO, PELOBIOTECH GmbH, UPM, and Cellendes GmbH. These players have adopted expansion, agreement, partnership, and collaboration as their key strategies to strengthen their foothold in the global market

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell culture hydrogel market analysis from 2023 to 2035 to identify the prevailing cell culture hydrogel market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the cell culture hydrogel market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global cell culture hydrogel market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type of Hydrogel

  • Synthetic Hydrogels
  • Hybrid Hydrogels
  • Natural Hydrogels

By Application

  • Cancer and Stem Cell Research
  • Tissue Engineering and Regenerative Medicine
  • Drug Discovery and Toxicology Testing
  • Others

By End User

  • Research Institutions
  • Others
  • Pharmaceutical and Biotechnology Companies
  • CROs

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Corning Incorporated
    • Merck KGaA
    • Humabiologics, Inc
    • UPM
    • PELOBIOTECH GmbH
    • CD Bioparticles
    • Cell Guidance Systems
    • BICO
    • TheWell Bioscience Inc.
    • Cellendes GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Applications in drug discovery and toxicology testing
      • 3.4.1.2. Rise in prevalence of chronic diseases and aging population
      • 3.4.1.3. Rise in demand for 3D cell culture
    • 3.4.2. Restraints
      • 3.4.2.1. Lack of a skilled workforce
    • 3.4.3. Opportunities
      • 3.4.3.1. High growth potential in emerging markets
      • 3.4.3.2. Advancements in biotechnology and life sciences

CHAPTER 4: CELL CULTURE HYDROGEL MARKET, BY TYPE OF HYDROGEL

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Natural Hydrogels
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Synthetic Hydrogels
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Hybrid Hydrogels
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: CELL CULTURE HYDROGEL MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Cancer and Stem Cell Research
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Tissue Engineering and Regenerative Medicine
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Drug Discovery and Toxicology Testing
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: CELL CULTURE HYDROGEL MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical and Biotechnology Companies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. CROs
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Research Institutions
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: CELL CULTURE HYDROGEL MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type of Hydrogel
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type of Hydrogel
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type of Hydrogel
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type of Hydrogel
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type of Hydrogel
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type of Hydrogel
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. India
      • 7.4.5.4.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type of Hydrogel
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type of Hydrogel
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Type of Hydrogel
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Type of Hydrogel
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Type of Hydrogel
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Corning Incorporated
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Merck KGaA
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Humabiologics, Inc
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Key strategic moves and developments
  • 9.4. BICO
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. TheWell Bioscience Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Key strategic moves and developments
  • 9.6. CD Bioparticles
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. PELOBIOTECH GmbH
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Cell Guidance Systems
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. UPM
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.7. Key strategic moves and developments
  • 9.10. Cellendes GmbH
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio